Compared to adjacent tissue, there is a decreased proportion of nuclear/cytoplasmic BARD1 in tumor samples (Fig. 6i and Supplementary Fig. 6g), indicating the specific upregulation of cytoplasmic BARD1 in BC tissues. This evidence concerns the gene BARD1 and breast cancer.